MetaCap

Ernexa Therapeutics (ERNA) News

NASDAQ: ERNAHealth CareBiotechnology: Pharmaceutical PreparationsUSD

1.36-0.27 (-16.56%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

ERNA news summary

We found 3 recent headlines mentioning Ernexa Therapeutics (ERNA): 1 in the past week and 1 in the past 30 days, most often from GlobeNewswire, Nasdaq. ERNA is making an outsized move today, down 16.56% at $1.36, which often coincides with company-specific news. Check the latest headlines below for the likely catalyst. The most recent story, "Ernexa Therapeutics Inc. Approves $5,000 Monthly Cash Compensation for CFO Mark J. Keeley", was published by Nasdaq on Nov 19, 2026.

Headlines link to the original publishers. MetaCap does not republish third-party articles.

Summary generated from market data by MetaCap's automated system. Methodology

Latest Ernexa Therapeutics headlines

Compare ERNA